Published in Adv Sex Horm Res on January 01, 1977
Biological actions of androgens. Endocr Rev (1987) 2.81
Differential effect of race on the axial and appendicular skeletons of children. J Clin Endocrinol Metab (1998) 2.50
Studies on the mechanism of steroid hormone regulation of synthesis of specific proteins. Recent Prog Horm Res (1969) 2.31
The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab (1976) 1.92
Specific estrogen binding by the cytoplasm fof human breast carcinoma. J Clin Endocrinol Metab (1970) 1.84
Studies on Leydig cell physiology and pathology: secretion and metabolism of testosterone. Recent Prog Horm Res (1966) 1.74
Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest (1975) 1.60
Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids (1969) 1.57
Evaluation of impotence in older men. West J Med (1985) 1.54
Radio-ligand binding assay of specific estrogens using a soluble uterine macromolecule. J Clin Endocrinol Metab (1968) 1.51
A radio-ligand binding assay system for estradiol measurement in human plasma. J Clin Endocrinol Metab (1969) 1.39
Estradiol radioimmunoassay without chromatography: procedure, validation and normal values. J Clin Endocrinol Metab (1974) 1.36
Reporting unethical research behavior. Eval Rev (1999) 1.28
Oestrogen window hypothesis of the aetiology of breast cancer. Lancet (1980) 1.18
Estrogen stimulation of synthesis of specific proteins and RNA polymerase activity in the immature chick oviduct. Biochim Biophys Acta (1967) 1.16
Measuring consensus about scientific research norms. Sci Eng Ethics (2000) 1.12
Protein kinase translocation as an early event in the hormonal control of uterine contraction. Science (1974) 1.09
Factors related to declining luteal function in women during the menopausal transition. J Clin Endocrinol Metab (2008) 1.07
Interaction of 17 -estradiol and its specific uterine receptor. Evidence for complex kinetic and equilibrium behavior. Biochemistry (1971) 1.07
Inadequate corpus luteum function: a pathophysiological interpretation of human breast cancer epidemiology. Cancer (1974) 1.06
The endocrinology of breast cancer. Cancer (1980) 1.06
Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase. J Clin Endocrinol Metab (1974) 1.05
Progesterone action: regulation of avidin biosynthesis by hen oviduct in vivo and in vitro. Endocrinology (1968) 1.05
Cultural-sensitivity training in U.S. medical schools. Acad Med (1994) 1.05
Measurement of plasma LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the short luteal phase. J Clin Endocrinol Metab (1974) 0.99
Use of a modified radioligand assay to measure the effect of estradiol on uterine adenosine 3',5'-cyclic monophosphate. Endocrinology (1973) 0.98
Reversible disaggregation of the cytosol-estrogen binding protein of uterine cytosol. Proc Natl Acad Sci U S A (1968) 0.98
Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review. Curr Drug Targets Immune Endocr Metabol Disord (2002) 0.95
Acute regulation of beta adrenergic catecholamine sensitivity in human lymphocytes. J Pharmacol Exp Ther (1980) 0.95
Testosterone replacement therapy and sleep-related erections in hypogonadal men. J Clin Endocrinol Metab (1990) 0.94
The endocrinology of the abnormal male breast. Ann N Y Acad Sci (1986) 0.93
Chromatographic purification of estradiol-17 for use in radio-ligand assay. Biochem Med (1970) 0.91
A radio-ligand assay for plasma estrone; normal values and variations during the menstrual cycle. J Clin Endocrinol Metab (1970) 0.91
Impotence in diabetic men. Am J Med (1988) 0.91
Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc (1988) 0.91
Further studies of gonadotropin and estradiol secretion during the preovulatory phase of the human menstrual cycle. J Clin Endocrinol Metab (1973) 0.90
The plasma estradiol as an index of fetoplacental function. J Clin Invest (1971) 0.89
Demonstration of adrenergic catecholamine receptors in rat myometrium and their regulation by sex steroid hormones. Life Sci (1978) 0.88
The endometrial adenosine cyclic 3':5'-monophosphate-dependent protein kinase. Distribution, subunit structure, and kinetics of adenosine cyclic 3':5'-monophosphate binding. J Biol Chem (1973) 0.88
The effect of weight loss on reproductive hormones in obese men. J Clin Endocrinol Metab (1981) 0.87
Estrogens and the human male. Annu Rev Med (1976) 0.87
Issues in testosterone replacement in older men. J Clin Endocrinol Metab (1998) 0.87
Studies on the mechanism of hormone induction of a specific protein. Immunological identity and kinetic studies of avidin synthesized in vitro by the chick oviduct. Life Sci (1967) 0.87
Age-related elevation of plasma catecholamine concentration and reduced responsiveness of lymphocyte adenylate cyclase. J Clin Endocrinol Metab (1981) 0.86
Relationship of penile brachial pressure index to myocardial infarction and cerebrovascular accidents in older men. Am J Med (1988) 0.85
Erectile dysfunction. J Clin Endocrinol Metab (2001) 0.83
Hormonal interactions in the uterus: inhibition of isoproterenol-induced accumulation of adenosine 3':5'-cyclic monophosphate by oxytocin and prostaglandins. Proc Natl Acad Sci U S A (1972) 0.83
Adenylate cyclase activation. Characterization of guanyl nucleotide requirements by direct radioligand-binding methods. J Biol Chem (1982) 0.83
Determination of the carboxyl-terminal amino acid residue of the beta-galactosidase of Escherichia coli K 12. Biochim Biophys Acta (1966) 0.83
Punishment for unethical behavior in the conduct of research. Acad Med (1998) 0.82
The ethics of scientific research: an analysis of focus groups of scientists and institutional representatives. J Investig Med (1997) 0.82
Radio-ligand procedures for estrogen assay in normal and pregnancy plasma. Acta Endocrinol Suppl (Copenh) (1970) 0.82
Systemic therapy for metastatic breast cancer. Ann Intern Med (1977) 0.81
Lymphocyte adenylate cyclase and human aging. Proc Soc Exp Biol Med (1983) 0.81
beta-Adrenergic catecholamine-dependent properties of rat myometrium primary cultures. Am J Physiol (1983) 0.81
beta-adrenergic catecholamine regulation of lymphocyte sensitivity: heterologous desensitization to prostaglandin E2 by isoproterenol. J Clin Endocrinol Metab (1980) 0.80
Activation of uterine smooth muscle adenylate cyclase by guanyl nucleotide. J Biol Chem (1981) 0.80
Endocrine aspects of aging. Ann Intern Med (1980) 0.80
Fractionation of chick oviduct chromatin: IV. Association of protein kinase with transcriptionally active chromatin. Biochem Biophys Res Commun (1975) 0.80
Distribution binding sites for the progesterone receptor within chick oviduct chromatin. Endocrinology (1976) 0.79
A radioligand assay for plasma unconjugated estriol in normal and abnormal pregnancies. Am J Obstet Gynecol (1971) 0.79
Association of elevated estradiol with remote testicular trauma in young infertile men. Fertil Steril (1994) 0.79
Reproductive hormone function: the perimenopausal period and beyond. Clin Endocrinol Metab (1978) 0.78
Coupling of beta-adrenoreceptors in rat uterine smooth muscle. Biol Reprod (1981) 0.78
Mechanism of androgenic action: effect of specific intracellular inhibitors. J Urol (1971) 0.78
Adenylate cyclase activation by GTP analogs. Arch Biochem Biophys (1982) 0.78
Interaction of prostaglandin E2 and beta-adrenergic catecholamines in the regulation of uterine smooth muscle motility and adenylate cyclase in the rat. J Endocrinol (1984) 0.78
Fractionation of chick oviduct chromatin. Nuclease-resistant deoxyribonucleic acid. Biochem J (1975) 0.78
The influence of aging on angiotensinogen production by rat vascular smooth muscle cells in vitro. Clin Exp Hypertens A (1988) 0.77
A kinetic analysis of activation of smooth muscle adenylate cyclase by forskolin. Arch Biochem Biophys (1984) 0.77
Influence of dopaminergic mechanisms on 24-hour secretory patterns of prolactin, luteinizing hormone and testosterone in recumbent men. J Endocrinol Invest (1983) 0.77
Hormonal control of uterine contraction. Characterization od cyclic AMP-dependent membrane properties in the myometrium. Biochim Biophys Acta (1976) 0.77
Evidence for reversibility of age-related decrease in human lymphocyte adenylate cyclase activity. Biochem Biophys Res Commun (1981) 0.77
The role of cyclic AMP in the regulation of smooth muscle cell contraction in the uterus. Biol Reprod (1977) 0.76
Phospholipid and guanine nucleotides sensitive properties of the smooth muscle adenylate cyclase catalytic unit. Biochemistry (1988) 0.76
Changes in inositol polyphosphate-sensitive calcium exchange in aortic smooth muscle cells in vitro. J Cell Physiol (1988) 0.76
Acute changes in noradrenaline levels do not alter lymphocyte beta-adrenergic receptor concentrations in man. Cardiovasc Res (1983) 0.76
Control of uterine contractility via cyclic AMP-dependent protein kinase. Ciba Found Symp (1977) 0.76
Menopausal endocrinology and management. Arch Intern Med (1982) 0.76
Endocrinology in aging. Dis Mon (1988) 0.76
Penile Raynaud's phenomenon: a possible cause of erectile failure. Am J Med (1988) 0.76
Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis. J Clin Endocrinol Metab (1995) 0.76
Kinetics and thermodynamics of activation of pretreatment with guanosine 5'-[beta, gamma-imido]triphosphate of smooth-muscle adenylate cyclase. Biochem J (1982) 0.75
Forskolin refractoriness. Exposure to the diterpene alters guanine nucleotide-dependent adenylate cyclase and calcium-uptake activity of cells cultured from the rat aorta. Biochem J (1987) 0.75
Myometrial protein kinase: hormone-stimulated translocation and membrane binding of the soluble enzyme. Arch Biochem Biophys (1978) 0.75
The role of cyclic GMP in cells with the properties of smooth muscle cultured from the rat myometrium. J Cell Physiol (1986) 0.75
Independent change of plasma and tissue renin in response to anesthetics. Clin Exp Hypertens A (1988) 0.75
The actions of thyroxine and tri-iodothyronine. Calif Med (1970) 0.75